BUY Krishna Institute of Medical Sciences Limited — Axis Securities
byAxis SecuritiesHorizon: NA (inferred 1–3 months)19 Aug 2026via Economic Times New Stock Recos
Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.
AI Assessment
Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.
RSI at 19 — oversold territory
Technicals · rsi·23 Oct · today
1 other SEBI-registered advisor has an active short-term BUY call on this stock, issued in the last 14 days
Advisor consensus · same horizon·19 Oct · 3d ago
4 advisors have active long-term BUY calls on this stock
Advisor consensus · adjacent horizon·9 Oct · 2w ago
Krishna Institute of Medical Sciences Ltd will acquire up to 22% equity stake in Splendid Hospitals Private Limited for an aggregate cash consideration of up to Rs 40 crore by way of primary infusion.
BSE · Company Update·6 Oct · 2w ago
Krishna Institute of Medical Sciences Ltd will acquire a 51% equity stake in Sarvottam Health Care Private Limited for up to Rs 80 crore, marking a strategic investment in the Kakinada healthcare mark
BSE · Company Update·6 Oct · 2w ago
Nothing found in this tip’s window yet.
MACD below its signal line — bearish momentum
Technicals · macd·23 Oct · today
Hospital stocks fall up to 6%: Apollo, Fortis, KIMS tumble as SC questions drug mark-ups
NewsEt-Markets·30 Sept · 3w ago
Explained - Why Hospital stocks Apollo, Max, Fortis, KIMS are down up to 7% on Wednesday
NewsCnbc-Tv18·30 Sept · 3w ago
Apollo, Max Health, Yatharth, KIMS hospital stocks under pressure after SC remarks on drug prices
NewsHbl·30 Sept · 3w ago
Apollo Hospitals, Max Health, Yatharth Hospital, KIMS, other hospital stocks under pressure as SC remarks on drug prices weigh
NewsHbl·30 Sept · 3w ago
Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.
Other calls on Krishna Institute of Medical Sciences
- BUY — Jigar S Patel, Anand Rathi19 Oct 2026 · ~3 months · target ₹800 · Active
- BUY — HSBC Securities9 Oct 2026 · ~1 year · target ₹865 · Active
- BUY — Goldman Sachs1 Oct 2026 · ~1 year · target ₹1,000 · Active
- BUY — Emkay Global1 Oct 2026 · ~1 year · target ₹850 · Active
- BUY — Rakesh Bansal24 Sept 2026 · ~2 weeks · target ₹831 · SL hit
More from Axis Securities
- BUY Eternal22 Oct 2026 · ~1 year · target ₹390 · Active
- BUY CCL Products (India)19 Oct 2026 · ~1 year · target ₹1,255 · Active
- BUY Federal Bank19 Oct 2026 · ~1 year · target ₹405 · Active
- BUY LTM19 Oct 2026 · ~1 year · target ₹4,960 · Active
- BUY Navin Fluorine International19 Oct 2026 · ~1 year · target ₹9,000 · Active

